Fresenius Targets Post-Warning Claims In Dialysis Drug MDL
Fresenius USA Inc. took aim Tuesday at one of hundreds of cases consolidated in multidistrict litigation over alleged side effects from its dialysis drugs GranuFlo and NaturaLyte, claiming that a woman...To view the full article, register now.
Already a subscriber? Click here to view full article